| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
2 companies
Chan Mitchell serves as a Chief Financial Officer at RGNX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $1.2M at current prices.
The biggest single holding is RGNX (~$1.1M) as Chief Financial Officer.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AVTX Avalo Therapeutics, Inc. | Director | Sell | 3,167 | $22.88 | $72,460.96 | -50.0% | -16.3% | - |